|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS | |||||||||||||||||||
| Cash | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Restricted cash | |||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $54,136 and $57,454, respectively | |||||||||||||||||||
| Unbilled accounts receivable | |||||||||||||||||||
| Other current assets | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Property and equipment, net | |||||||||||||||||||
| Lease right of use asset | |||||||||||||||||||
| Intangible assets, net | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Deferred tax assets, net | |||||||||||||||||||
| Other long-term assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| CURRENT LIABILITIES | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accrued expenses | |||||||||||||||||||
| Current portion of deferred revenue | |||||||||||||||||||
| Current portion of lease liabilities | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| NONCURRENT LIABILITIES | |||||||||||||||||||
| Lease liabilities, net of current portion | |||||||||||||||||||
| Contingent consideration | |||||||||||||||||||
| Deferred revenue, net of current portion | |||||||||||||||||||
| Deferred tax liabilities, net | |||||||||||||||||||
| Deferred tax liabilities, net | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Commitments and contingencies (Note 14) | |||||||||||||||||||
| Commitments and contingencies (Note 16) | |||||||||||||||||||
| STOCKHOLDERS' EQUITY | |||||||||||||||||||
| Preferred stock, $0.001 par value; 10,000,000 shares authorized; 2,045,714 shares issued and none outstanding | |||||||||||||||||||
| Common stock, $0.001 par value; 30,000,000 shares authorized; 9,994,617 and 9,892,565 shares issued and outstanding, respectively | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Total stockholders' equity | |||||||||||||||||||
| Total liabilities and stockholders' equity | |||||||||||||||||||
Loading...
